CN116004500A - 一种生产l-缬氨酸的基因工程菌及其构建方法与应用 - Google Patents
一种生产l-缬氨酸的基因工程菌及其构建方法与应用 Download PDFInfo
- Publication number
- CN116004500A CN116004500A CN202211742130.3A CN202211742130A CN116004500A CN 116004500 A CN116004500 A CN 116004500A CN 202211742130 A CN202211742130 A CN 202211742130A CN 116004500 A CN116004500 A CN 116004500A
- Authority
- CN
- China
- Prior art keywords
- gene encoding
- gene
- valine
- genetically engineered
- engineered bacterium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 title claims abstract description 133
- 229960004295 valine Drugs 0.000 title claims abstract description 64
- 241000894006 Bacteria Species 0.000 title claims abstract description 36
- 238000010276 construction Methods 0.000 title abstract description 8
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 69
- 241000588724 Escherichia coli Species 0.000 claims abstract description 55
- 101150090497 ilvC gene Proteins 0.000 claims abstract description 18
- 102220311820 rs1376867262 Human genes 0.000 claims abstract description 16
- 101150087106 pncB gene Proteins 0.000 claims abstract description 15
- 101150091634 bcd gene Proteins 0.000 claims abstract description 14
- 101150091570 gapA gene Proteins 0.000 claims abstract description 14
- 101150043028 ilvD gene Proteins 0.000 claims abstract description 14
- 101150058595 MDH gene Proteins 0.000 claims abstract description 13
- 241000186226 Corynebacterium glutamicum Species 0.000 claims abstract description 12
- 108010028127 Dihydrolipoamide Dehydrogenase Proteins 0.000 claims abstract description 11
- 102000004316 Oxidoreductases Human genes 0.000 claims abstract description 10
- 108090000854 Oxidoreductases Proteins 0.000 claims abstract description 10
- 102220570852 Protein CFAP210_L67E_mutation Human genes 0.000 claims abstract description 10
- 244000063299 Bacillus subtilis Species 0.000 claims abstract description 9
- 235000014469 Bacillus subtilis Nutrition 0.000 claims abstract description 9
- 102000028526 Dihydrolipoamide Dehydrogenase Human genes 0.000 claims abstract description 8
- 108700016168 Dihydroxy-acid dehydratases Proteins 0.000 claims abstract description 8
- 102000000780 Nicotinate phosphoribosyltransferase Human genes 0.000 claims abstract description 8
- 108700040046 Nicotinate phosphoribosyltransferases Proteins 0.000 claims abstract description 8
- 108010000700 Acetolactate synthase Proteins 0.000 claims abstract description 7
- 108010028658 Leucine Dehydrogenase Proteins 0.000 claims abstract description 6
- 102000013460 Malate Dehydrogenase Human genes 0.000 claims abstract description 6
- 108010026217 Malate Dehydrogenase Proteins 0.000 claims abstract description 6
- 150000005693 branched-chain amino acids Chemical class 0.000 claims abstract description 6
- 102000003939 Membrane transport proteins Human genes 0.000 claims abstract description 5
- 108090000301 Membrane transport proteins Proteins 0.000 claims abstract description 5
- 101710088194 Dehydrogenase Proteins 0.000 claims abstract description 3
- LXJXRIRHZLFYRP-UHFFFAOYSA-N glyceraldehyde 3-phosphate Chemical compound O=CC(O)COP(O)(O)=O LXJXRIRHZLFYRP-UHFFFAOYSA-N 0.000 claims abstract 2
- 238000000034 method Methods 0.000 claims description 30
- 238000004519 manufacturing process Methods 0.000 claims description 26
- 239000001963 growth medium Substances 0.000 claims description 11
- 239000002609 medium Substances 0.000 claims description 11
- 150000001413 amino acids Chemical group 0.000 claims description 10
- 238000012258 culturing Methods 0.000 claims description 10
- 102000006602 glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 claims description 6
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 claims description 6
- 150000004715 keto acids Chemical class 0.000 claims description 5
- 230000000415 inactivating effect Effects 0.000 claims description 4
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims description 2
- 239000004473 Threonine Substances 0.000 claims description 2
- 235000004279 alanine Nutrition 0.000 claims description 2
- 125000003295 alanine group Chemical group N[C@@H](C)C(=O)* 0.000 claims 1
- 238000012262 fermentative production Methods 0.000 claims 1
- 125000000341 threoninyl group Chemical group [H]OC([H])(C([H])([H])[H])C([H])(N([H])[H])C(*)=O 0.000 claims 1
- 238000010353 genetic engineering Methods 0.000 abstract description 8
- 239000012634 fragment Substances 0.000 description 65
- 238000011144 upstream manufacturing Methods 0.000 description 59
- 238000000855 fermentation Methods 0.000 description 33
- 230000004151 fermentation Effects 0.000 description 33
- 239000013612 plasmid Substances 0.000 description 30
- 230000010354 integration Effects 0.000 description 18
- 238000006243 chemical reaction Methods 0.000 description 15
- 210000004027 cell Anatomy 0.000 description 14
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 12
- 239000008103 glucose Substances 0.000 description 12
- 101150040445 lpd gene Proteins 0.000 description 12
- 108020004414 DNA Proteins 0.000 description 11
- 238000000137 annealing Methods 0.000 description 10
- 238000001962 electrophoresis Methods 0.000 description 10
- 101100125907 Streptomyces coelicolor (strain ATCC BAA-471 / A3(2) / M145) ilvC1 gene Proteins 0.000 description 9
- 239000002253 acid Substances 0.000 description 9
- 230000014509 gene expression Effects 0.000 description 9
- 238000003786 synthesis reaction Methods 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 230000015572 biosynthetic process Effects 0.000 description 8
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 8
- 235000001014 amino acid Nutrition 0.000 description 6
- 229940041514 candida albicans extract Drugs 0.000 description 6
- 238000013461 design Methods 0.000 description 6
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 238000012216 screening Methods 0.000 description 6
- 239000012138 yeast extract Substances 0.000 description 6
- 229940024606 amino acid Drugs 0.000 description 5
- 238000012269 metabolic engineering Methods 0.000 description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- 230000001276 controlling effect Effects 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 238000011218 seed culture Methods 0.000 description 4
- 239000001509 sodium citrate Substances 0.000 description 4
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 4
- 229940113082 thymine Drugs 0.000 description 4
- 229930024421 Adenine Natural products 0.000 description 3
- 239000001888 Peptone Substances 0.000 description 3
- 108010080698 Peptones Proteins 0.000 description 3
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 229960000643 adenine Drugs 0.000 description 3
- GFFGJBXGBJISGV-UHFFFAOYSA-N adenyl group Chemical group N1=CN=C2N=CNC2=C1N GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 3
- 230000003321 amplification Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000003209 gene knockout Methods 0.000 description 3
- 238000010362 genome editing Methods 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- 239000002773 nucleotide Substances 0.000 description 3
- 125000003729 nucleotide group Chemical group 0.000 description 3
- 230000002018 overexpression Effects 0.000 description 3
- 230000037361 pathway Effects 0.000 description 3
- 235000019319 peptone Nutrition 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 2
- 101100316752 Arabidopsis thaliana VAL1 gene Proteins 0.000 description 2
- 101100316753 Arabidopsis thaliana VAL2 gene Proteins 0.000 description 2
- 101100316754 Arabidopsis thaliana VAL3 gene Proteins 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 108020005004 Guide RNA Proteins 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241000319304 [Brevibacterium] flavum Species 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 235000015278 beef Nutrition 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
- 230000010435 extracellular transport Effects 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 101150073818 gap gene Proteins 0.000 description 2
- 238000013537 high throughput screening Methods 0.000 description 2
- 101150105723 ilvD1 gene Proteins 0.000 description 2
- 239000013028 medium composition Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 101150100149 rph gene Proteins 0.000 description 2
- 238000007790 scraping Methods 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 101150107208 ygaY gene Proteins 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 101100456369 Aquifex aeolicus (strain VF5) mdh1 gene Proteins 0.000 description 1
- 101100052473 Bacillus subtilis (strain 168) ycgH gene Proteins 0.000 description 1
- 101100488216 Bacillus subtilis (strain 168) yesE gene Proteins 0.000 description 1
- 108091033409 CRISPR Proteins 0.000 description 1
- 238000010356 CRISPR-Cas9 genome editing Methods 0.000 description 1
- 241001485655 Corynebacterium glutamicum ATCC 13032 Species 0.000 description 1
- 101100190555 Dictyostelium discoideum pkgB gene Proteins 0.000 description 1
- 101100101130 Escherichia coli (strain K12) ttdR gene Proteins 0.000 description 1
- 101100376115 Escherichia coli (strain K12) yeeL gene Proteins 0.000 description 1
- 101100431984 Escherichia coli (strain K12) yeeP gene Proteins 0.000 description 1
- 101100544116 Escherichia coli (strain K12) yghX gene Proteins 0.000 description 1
- 101100160176 Escherichia coli (strain K12) yjiP gene Proteins 0.000 description 1
- 101100160180 Escherichia coli (strain K12) yjiT gene Proteins 0.000 description 1
- 241000901842 Escherichia coli W Species 0.000 description 1
- 241000701959 Escherichia virus Lambda Species 0.000 description 1
- 101150039774 GAPA1 gene Proteins 0.000 description 1
- 241000701047 Gallid alphaherpesvirus 2 Species 0.000 description 1
- 206010064571 Gene mutation Diseases 0.000 description 1
- 108700007698 Genetic Terminator Regions Proteins 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 101100384788 Methanocaldococcus jannaschii (strain ATCC 43067 / DSM 2661 / JAL-1 / JCM 10045 / NBRC 100440) comC gene Proteins 0.000 description 1
- 101100020705 Mycoplasma gallisepticum (strain R(low / passage 15 / clone 2)) ldh gene Proteins 0.000 description 1
- ACFIXJIJDZMPPO-NNYOXOHSSA-N NADPH Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](OP(O)(O)=O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 ACFIXJIJDZMPPO-NNYOXOHSSA-N 0.000 description 1
- 101100282114 Pseudomonas aeruginosa (strain UCBPP-PA14) gap2 gene Proteins 0.000 description 1
- 101100453320 Pyrococcus furiosus (strain ATCC 43587 / DSM 3638 / JCM 8422 / Vc1) pfkC gene Proteins 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
- 102000012751 Pyruvate Dehydrogenase Complex Human genes 0.000 description 1
- 108010090051 Pyruvate Dehydrogenase Complex Proteins 0.000 description 1
- 101100290490 Rattus norvegicus Mdh1 gene Proteins 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 101100029403 Synechocystis sp. (strain PCC 6803 / Kazusa) pfkA2 gene Proteins 0.000 description 1
- 241001052560 Thallis Species 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 101150015189 aceE gene Proteins 0.000 description 1
- 101150077561 aceF gene Proteins 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- MLYYVTUWGNIJIB-BXKDBHETSA-N cefazolin Chemical compound S1C(C)=NN=C1SCC1=C(C(O)=O)N2C(=O)[C@@H](NC(=O)CN3N=NN=C3)[C@H]2SC1 MLYYVTUWGNIJIB-BXKDBHETSA-N 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 229940104302 cytosine Drugs 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000013613 expression plasmid Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000034659 glycolysis Effects 0.000 description 1
- 101150020087 ilvG gene Proteins 0.000 description 1
- 238000000126 in silico method Methods 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 229910001410 inorganic ion Inorganic materials 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 108700010833 lambda phage proteins Proteins 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 101150066970 mbhA gene Proteins 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 238000005374 membrane filtration Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 150000007523 nucleic acids Chemical group 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 101150038284 pfkA gene Proteins 0.000 description 1
- 101150004013 pfkA1 gene Proteins 0.000 description 1
- 101150060387 pfp gene Proteins 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 229940076788 pyruvate Drugs 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003362 replicative effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 101150079835 rpnD gene Proteins 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000002741 site-directed mutagenesis Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- WPLOVIFNBMNBPD-ATHMIXSHSA-N subtilin Chemical compound CC1SCC(NC2=O)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(C(C)CC)C(=O)NC(=C)C(=O)NC(CCCCN)C(O)=O)CSC(C)C2NC(=O)C(CC(C)C)NC(=O)C1NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C1NC(=O)C(=C/C)/NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C2NC(=O)CNC(=O)C3CCCN3C(=O)C(NC(=O)C3NC(=O)C(CC(C)C)NC(=O)C(=C)NC(=O)C(CCC(O)=O)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(N)CC=4C5=CC=CC=C5NC=4)CSC3)C(C)SC2)C(C)C)C(C)SC1)CC1=CC=CC=C1 WPLOVIFNBMNBPD-ATHMIXSHSA-N 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000011222 transcriptome analysis Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 1
- 150000003627 tricarboxylic acid derivatives Chemical class 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 101150008946 ycjV gene Proteins 0.000 description 1
- 101150107566 ydeU gene Proteins 0.000 description 1
- 101150110708 yghE gene Proteins 0.000 description 1
- 101150063727 yjiT gene Proteins 0.000 description 1
Images
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211742130.3A CN116004500A (zh) | 2022-12-29 | 2022-12-29 | 一种生产l-缬氨酸的基因工程菌及其构建方法与应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211742130.3A CN116004500A (zh) | 2022-12-29 | 2022-12-29 | 一种生产l-缬氨酸的基因工程菌及其构建方法与应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116004500A true CN116004500A (zh) | 2023-04-25 |
Family
ID=86028155
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211742130.3A Pending CN116004500A (zh) | 2022-12-29 | 2022-12-29 | 一种生产l-缬氨酸的基因工程菌及其构建方法与应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116004500A (zh) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116536237A (zh) * | 2023-06-29 | 2023-08-04 | 北京中科伊品生物科技有限公司 | 改造的大肠杆菌及其在发酵生产l-缬氨酸中的应用 |
CN116536236A (zh) * | 2023-06-29 | 2023-08-04 | 北京中科伊品生物科技有限公司 | 一种重组菌及其在生产l-缬氨酸中的应用 |
CN116555153A (zh) * | 2023-07-04 | 2023-08-08 | 黑龙江伊品生物科技有限公司 | 一种用于生产l-缬氨酸的大肠杆菌的构建方法与应用 |
CN116555155A (zh) * | 2023-07-04 | 2023-08-08 | 黑龙江伊品生物科技有限公司 | 用于生产l-缬氨酸的大肠杆菌及其构建方法与应用 |
CN116555150A (zh) * | 2023-06-27 | 2023-08-08 | 北京中科伊品生物科技有限公司 | 用于发酵生产l-缬氨酸的重组大肠杆菌 |
CN116555154A (zh) * | 2023-07-04 | 2023-08-08 | 黑龙江伊品生物科技有限公司 | 用于生产l-缬氨酸的大肠杆菌及其构建方法 |
CN116555156A (zh) * | 2023-07-04 | 2023-08-08 | 北京中科伊品生物科技有限公司 | 一种提高l-缬氨酸产量的方法及其使用的重组菌 |
CN116555151A (zh) * | 2023-07-04 | 2023-08-08 | 黑龙江伊品生物科技有限公司 | 产l-缬氨酸工程菌及构建方法与应用 |
CN116555152B (zh) * | 2023-07-04 | 2023-10-20 | 黑龙江伊品生物科技有限公司 | 大肠杆菌及其构建方法与在生产l-缬氨酸中的应用 |
-
2022
- 2022-12-29 CN CN202211742130.3A patent/CN116004500A/zh active Pending
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116555150A (zh) * | 2023-06-27 | 2023-08-08 | 北京中科伊品生物科技有限公司 | 用于发酵生产l-缬氨酸的重组大肠杆菌 |
CN116555150B (zh) * | 2023-06-27 | 2023-10-31 | 北京中科伊品生物科技有限公司 | 用于发酵生产l-缬氨酸的重组大肠杆菌 |
CN116536236B (zh) * | 2023-06-29 | 2023-09-19 | 北京中科伊品生物科技有限公司 | 一种重组菌及其在生产l-缬氨酸中的应用 |
CN116536237A (zh) * | 2023-06-29 | 2023-08-04 | 北京中科伊品生物科技有限公司 | 改造的大肠杆菌及其在发酵生产l-缬氨酸中的应用 |
CN116536237B (zh) * | 2023-06-29 | 2023-11-10 | 北京中科伊品生物科技有限公司 | 改造的大肠杆菌及其在发酵生产l-缬氨酸中的应用 |
CN116536236A (zh) * | 2023-06-29 | 2023-08-04 | 北京中科伊品生物科技有限公司 | 一种重组菌及其在生产l-缬氨酸中的应用 |
CN116555154B (zh) * | 2023-07-04 | 2023-09-22 | 黑龙江伊品生物科技有限公司 | 用于生产l-缬氨酸的大肠杆菌及其构建方法 |
CN116555151A (zh) * | 2023-07-04 | 2023-08-08 | 黑龙江伊品生物科技有限公司 | 产l-缬氨酸工程菌及构建方法与应用 |
CN116555156A (zh) * | 2023-07-04 | 2023-08-08 | 北京中科伊品生物科技有限公司 | 一种提高l-缬氨酸产量的方法及其使用的重组菌 |
CN116555155A (zh) * | 2023-07-04 | 2023-08-08 | 黑龙江伊品生物科技有限公司 | 用于生产l-缬氨酸的大肠杆菌及其构建方法与应用 |
CN116555153B (zh) * | 2023-07-04 | 2023-09-29 | 黑龙江伊品生物科技有限公司 | 一种用于生产l-缬氨酸的大肠杆菌的构建方法与应用 |
CN116555151B (zh) * | 2023-07-04 | 2023-10-17 | 黑龙江伊品生物科技有限公司 | 产l-缬氨酸工程菌及构建方法与应用 |
CN116555152B (zh) * | 2023-07-04 | 2023-10-20 | 黑龙江伊品生物科技有限公司 | 大肠杆菌及其构建方法与在生产l-缬氨酸中的应用 |
CN116555155B (zh) * | 2023-07-04 | 2023-10-24 | 黑龙江伊品生物科技有限公司 | 用于生产l-缬氨酸的大肠杆菌及其构建方法与应用 |
CN116555156B (zh) * | 2023-07-04 | 2023-10-31 | 北京中科伊品生物科技有限公司 | 一种提高l-缬氨酸产量的方法及其使用的重组菌 |
CN116555154A (zh) * | 2023-07-04 | 2023-08-08 | 黑龙江伊品生物科技有限公司 | 用于生产l-缬氨酸的大肠杆菌及其构建方法 |
CN116555153A (zh) * | 2023-07-04 | 2023-08-08 | 黑龙江伊品生物科技有限公司 | 一种用于生产l-缬氨酸的大肠杆菌的构建方法与应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN116004500A (zh) | 一种生产l-缬氨酸的基因工程菌及其构建方法与应用 | |
CN110607268B (zh) | 一株高产l-缬氨酸的基因工程菌及发酵生产l-缬氨酸方法 | |
Du et al. | Engineering Halomonas bluephagenesis for L-Threonine production | |
CN114717172B (zh) | 合成l-缬氨酸的大肠杆菌及其构建方法与应用 | |
CN109536428B (zh) | 一种产l-异亮氨酸的基因工程菌及其构建方法和应用 | |
Guo et al. | Enhancing tryptophan production by balancing precursors in Escherichia coli | |
CN114457122B (zh) | 生产l-缬氨酸的重组微生物及构建方法、应用 | |
WO2022174597A1 (zh) | 一种用于l-肌氨酸生产的基因工程菌及构建方法与应用 | |
CN111705030B (zh) | 高产l-高丝氨酸的大肠杆菌基因工程菌、构建方法及菌株 | |
CN115806929A (zh) | 一种生产l-精氨酸的基因工程菌及其应用 | |
WO2018077159A1 (zh) | 氨基酸衰减子的改造方法及其在生产中的应用 | |
CN109456987B (zh) | 高产l-亮氨酸的相关基因及工程菌构建方法与应用 | |
CN113652383B (zh) | 一种高产d-泛酸的基因工程菌及其应用 | |
WO2024099089A1 (zh) | 一种生产假尿苷的基因工程菌株及其构建方法与应用 | |
CN110387344B (zh) | 生产l-亮氨酸的重组菌、其构建方法及l-亮氨酸的生产方法 | |
CN116121161B (zh) | 一种生产麦角硫因的基因工程菌及其构建方法与应用 | |
KR100498971B1 (ko) | 염색체 내 tdcBC 및 pckA 유전자가 불활성화된 미생물 및 이를 이용하여 L-쓰레오닌을 제조하는 방법 | |
CN110452920A (zh) | 一种基因工程菌及以d,l-扁桃酸为底物制备l-苯甘氨酸的方法 | |
CN117844728B (zh) | 一种l-缬氨酸生产菌株及其构建方法与应用 | |
CN117925666B (zh) | 一种l-异亮氨酸生产菌株及其构建方法与应用 | |
CN111154706B (zh) | L-色氨酸产量提高的重组大肠杆菌及其构建方法与应用 | |
CN115651882B (zh) | 基于动态调控硫回收利用的l-半胱氨酸工程菌的构建方法与应用 | |
CN118006652B (zh) | 一种多巴胺生产菌株及其构建方法与应用 | |
CN116121161A (zh) | 一种生产麦角硫因的基因工程菌及其构建方法与应用 | |
WO2023246071A1 (zh) | 一种mreC突变体及其在L-缬氨酸发酵生产中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20240310 Address after: 750100 Yang Yang Industrial Park, Yongning County, the Ningxia Hui Autonomous Region, Yinchuan Applicant after: NINGXIA EPPEN BIOTECH Co.,Ltd. Country or region after: China Address before: No.9, 13th Street, economic and Technological Development Zone, Binhai New Area, Tianjin Applicant before: TIANJIN University OF SCIENCE AND TECHNOLOGY Country or region before: China Applicant before: NINGXIA EPPEN BIOTECH Co.,Ltd. |